Boehringer Ingelheim Venture Fund For Profit
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Invests into
Founded Date:
2010-01-01
Investor Type:
Corporate Venture Capital
Employee Number:
11-50
Investment Stage:
Early Stage Venture, Seed
Number Of Exists:
8
Industry:
Omics-Based Biomarkers
Headquarters:
Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Estimated Revenue:
$1M to $10M